The 238U, 232Th and 40K concentrations were estimated in the size-fractionated urban surface deposited sediments in Ekaterinburg, Russia. The average concentrations of 238U, 232Th and 40K in dust fraction (0.002-0.05 mm) are 48 ± 7, 28 ± 1 and 510 ± 20 Bq/kg, respectively. The effective dose is estimated depending on the suggested daily scenarios of different exercises which can be assigned to light, moderate and vigorous activity. The results show that the total effective dose received during 20 years by an adult with the light activity is 5.6 μSv under exposure to air dust concentration 1 × 10-4 g/m3, which is typical for the city of Ekaterinburg. Although for the moderate and vigorous activities the total effective dose is 9.9 μSv and 48.8 μSv, respectively, during 20 years at air dust concentration equal to the diurnal Maximum Permissible Limit (1.5 × 10-4 g/m3). Thus, the effective doses due to natural radionuclides in the dust fraction are relatively low in comparison ICRP reference level.

Download full-text PDF

Source
http://dx.doi.org/10.1093/rpd/ncab148DOI Listing

Publication Analysis

Top Keywords

effective dose
12
natural radionuclides
8
238u 232th
8
232th 40k
8
dust fraction
8
moderate vigorous
8
total effective
8
air dust
8
dust concentration
8
dust
5

Similar Publications

Background: Prophylactic parenteral administration of antibiotics is strongly recommended to prevent surgical site infection (SSI). Cefoxitin is mainly administered intravenously in colorectal surgery. The current standard method for administering prophylactic antibiotics in adults is to administer a fixed dose quickly before skin incision.

View Article and Find Full Text PDF

Purpose: In this retrospective study, we aimed to evaluate the efficacy and incidence of radiation-induced brain necrosis (RBN) after volumetric modulated arc therapy-based stereotactic irradiation (VMAT-STI) for brain metastases.

Methods: In the 220 brain metastatic lesions included between January 2020 and June 2022, there were 1-9 concurrently treated lesions (median 1). A biologically effective dose (BED)10 of 80 Gy and a reduced BED10 of 50 Gy were prescribed to the gross tumor volume (GTV) and planning target volume (PTV) (PTV = GTV + 3 mm) margins, respectively.

View Article and Find Full Text PDF

Background: This in vitro study evaluated the efficacy of professional and home-use fluoride regimens for protecting irradiated enamel, undergoing pH cycling resembling xerostomia.

Methods: Sixty human premolar teeth were irradiated with a total dose of 70 Gy and subsequently sectioned into 3 × 3 cm enamel slabs. These slabs were randomly distributed into five groups (n = 12 per group): professional-use groups received fluoride varnish either weekly (FV1) or biweekly (FV2); home-use groups applied 5000 ppm (FT5) or 1450 ppm (FT) fluoride toothpaste; and a control group (control) received no treatment.

View Article and Find Full Text PDF

Background: Acute exacerbation (AEx) of interstitial pneumonia is the most common lethal adverse event related to the pharmacological treatment of patients with lung cancer complicated with interstitial pneumonia. Although small cell lung cancer (SCLC) is linked to poor prognosis, it exhibits good response to chemotherapy. Few previous research studies have investigated the safety and efficacy of treatment for advanced SCLC complicated with idiopathic interstitial pneumonia (IIP).

View Article and Find Full Text PDF

Background And Aim: Zinc oxide and copper oxide nanoparticles are known for their promising biological activities. This study aims to synthesize zinc oxide nanoparticles and copper-doped zinc oxide nanoparticles to harness the combined cytotoxic and anticancer effects of them in vitro and in vivo studies.

Methods: Zinc oxide nanoparticles, both doped and undoped, were synthesized using a chemical co-precipitation method.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!